Advertisement
Upon hospital admission

Lack of Consistent Supplement Use Documentation for Inpatients

0
While more than half of patients used prior to hospitalization, most were not asked upon admission
Pharmacist-managed warfarin therapy is superior to a usual medical care model for management of warfarin therapy

Pharmacist-Managed Warfarin Therapy Beats Usual Care

0
Percentage of time in therapeutic range, major bleeding events, hospitalization all in favor of PMWT
For Korean patients with acne

Dermatologist Tutorial Helps Minimize Acne Rx Side Effects

0
Improved tolerability with dermatologists' tutorials for application methods with A-BPO
Most edible cannabis products sampled in three major U.S. cities are mislabeled

Edible Cannabis Products Often Mislabeled

0
Sixty percent contained less active ingredient than label said, while 23 percent had more
A new review of data involving over 20

Viagra, Other ED Meds Don’t Raise Melanoma Risk

0
Slightly higher odds for men on ED drugs, but lifestyles are probable culprit
Researchers report that a drug for rheumatoid arthritis may be a promising treatment for vitiligo. The findings were published online June 24 in JAMA Dermatology.

Drug for Rheumatoid Arthritis May Also Help Ease Vitiligo

0
Case study showed tofacitinib cleared up skin pigmentation loss in woman after just two months
Use of acid suppression medication is associated with increased risk of Clostridium difficile infection in infants and children

Acid Suppression Medications Up C. difficile Risk in Children

0
Increased risk for children aged younger than 1 and for those aged 1 to 17 years
Optimal management of subtherapeutic international normalized ratios is unclear

Variability Identified in Bridging Practices Among Pharmacists

0
In some scenarios, significant differences with varying levels of experience, residency training
A joint clinical practice guideline for the management of dyslipidemia for cardiovascular disease risk reduction in adults has been summarized and published online June 22 in the Annals of Internal Medicine.

VA/DoD Release Guidelines for Dyslipidemia Management

0
Key features include elimination of treatment targets, additional testing only when rationale clear
Kengreal (cangrelor) has been approved by the U.S. Food and Drug Administration to prevent blood clots from forming during angioplasty.

FDA Approves New Antiplatelet Drug for Patients Undergoing PCI

0
Kengreal prevents blood platelets from accumulating during percutaneous coronary intervention